![]() |
市場調査レポート
商品コード
1801003
麻酔用気管内チューブの市場レポート:挿管タイプ別、製品タイプ別、エンドユーザー別、地域別、2025~2033年Anesthesia Endotracheal Tubes Market Report by Intubation Type, Product Type, End User, and Region 2025-2033 |
||||||
カスタマイズ可能
|
麻酔用気管内チューブの市場レポート:挿管タイプ別、製品タイプ別、エンドユーザー別、地域別、2025~2033年 |
出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2~3営業日
|
世界の麻酔用気管内チューブの市場規模は、2024年に1億9,130万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに2億9,180万米ドルに達し、2025~2033年の成長率(CAGR)は4.56%を示すと予測しています。
麻酔用気管内チューブ(ETT)は挿管に使用され、ポリ塩化ビニル(PVC)チューブを使用して製造され、気管に挿入して酸素(O2)の直接供給と肺からの二酸化炭素(CO2)の除去を可能にします。このチューブは、肺の気道通過性を維持し、機械的換気を可能にします。また、胃内容物や鼻咽頭物質の汚染から肺を保護したり、間欠的陽圧換気(IPPV)、蘇生、ジフテリア、喉頭蓋、メコニウム吸引時の気管直接吸引の際にも使用されます。ETTは、ヘルスケア専門家が患者を鎮静化し、外科手術を行うことを可能にします。その結果、ETTは手術センター、外傷センター、集中治療室(ICU)などで広く使用されています。
大衆の間で慢性疾患やウイルス感染症、特にこれらの医療疾患にかかりやすい高齢者人口が増加していることは、世界の麻酔用気管内チューブの需要にプラスの影響を与えている主な要因の1つです。さらに、死亡交通事故件数の増加と外傷症例の増加が市場を牽引しています。また、主要企業は、ユーザーに快適さと利便性を提供し、最小限の不快感で脆弱な気道を通過するのに役立つ、柔軟な先端を持つ麻酔用気管内チューブを導入しています。さらに、喫煙者やアルコール消費者の増加が市場の成長に寄与しています。加えて、大気汚染の増加に伴う空気感染性疾患の増加も、市場に明るい展望をもたらしています。このほか、ヘルスケアインフラと医療サービスの改善への投資が拡大しており、業界の投資家に有利な成長機会を提供すると予測されています。
The global anesthesia endotracheal tubes market size reached USD 191.3 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 291.8 Million by 2033, exhibiting a growth rate (CAGR) of 4.56% during 2025-2033.
Anesthesia endotracheal tubes (ETTs) are used for intubation and manufactured using a polyvinylchloride (PVC) tube, which is inserted into the trachea and allows direct delivery of oxygen (O2) and removal of carbon dioxide (CO2) from the lungs. They aid in maintaining the airway passage of the lungsand allowing mechanical ventilation. They are also utilizedfor protecting the lungs from contamination of gastric contents and nasopharyngeal matter and during intermittent positive pressure ventilation (IPPV), resuscitation, Diptheria, epiglottis, and direct suctioning of the trachea in meconium aspiration. They enable healthcare professionals to sedate the patient and performing the surgical procedure. As a result, ETTsare widely used in surgery centers, trauma centers, and intensive care units (ICUs).
The increasing prevalence of chronic disorders and viral infections among the masses, especially the geriatric population, which is more susceptible to thesemedical ailments, represents one of the major factors positively influencing the demand for anesthesia ETTs worldwide. In addition, the rising number of fatal road accidents and the growing number of trauma cases are driving the market. Apart from this, key players are introducing anesthesia ETTs with flexible tips that offer enhanced comfort and convenience to the users and assist in navigating through fragile airways with minimal discomfort. Furthermore, the escalating number of smokers and alcohol consumers is contributing to the market growth. Moreover, increasing incidences of airborne diseases on account of the rising air pollution arecreating a positive outlook in the market. Besides this, the expanding investments in improving healthcare infrastructure and medical services are projected to offer lucrative growth opportunities to industry investors.
Nasotracheal intubation dominates the market as it is easier to secure, moves less, minimizes the risk of trauma to lips, tongue, and larynx, and provides comfort to patients.
Coated tubes currently dominate the market.
Anesthesia endotracheal tubes are extensively used in hospitals as it is an emergency procedure performed on people to maintain an open airway and help prevent suffocation.
North America holds the majority of the global anesthesia endotracheal tubes market share due to the increasing prevalence of severe chronic ailments among the masses of the region.
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Becton, Dickinson and Company, Convatec Limited, Fuji Systems Corp., General Electric (GE) Company, Intersurgical Ltd., Medtronic Private Limited, Neurovision Medical Products, SEWOON MEDICAL Co., Ltd., Smiths Group PLC, and Teleflex Incorporated.